SMMT

Summit Therapeutics Inc Earnings

$18.17

Earnings Summary

Revenue	$0Mn
Net Profits	$-231.79Mn
Net Profit Margins	-Inf%

Highlights

Revenue:

Summit Therapeutics Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q3 2025. On a quarterly growth basis, Summit Therapeutics Inc has generated NaN% jump in its revenue since last 3-months.

Net Profits:

Summit Therapeutics Inc’s net profit fell -312.05% since last year same period to $-231.79Mn in the Q3 2025. On a quarterly growth basis, Summit Therapeutics Inc has generated 0% jump in its net profits since last 3-months.

Net Profit Margins:

Summit Therapeutics Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q3 2025. On a quarterly growth basis, Summit Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Summit Therapeutics Inc post its latest quarter earnings

EPS Estimate Current Quarter	-0.18
EPS Estimate Current Year	-0.18

Highlights

EPS Estimate Current Quarter:

Summit Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.18 - a -72.97% fall from last quarter’s estimates.

EPS Estimate Current Year:

Summit Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.18.

Key Ratios

Key ratios of the Summit Therapeutics Inc post its Q3 2025 earnings

Earning Per Share (EPS)

-0.23

Highlights

Earning Per Share (EPS):

Summit Therapeutics Inc’s earning per share (EPS) fell -189.38% since last year same period to -0.23 in the Q3 2025. This indicates that the Summit Therapeutics Inc has generated -189.38% annual rate of fall in its earning per share (EPS) in the last 4 quarters.